News: Jill Scoggins

Jill Scoggins

All News Stories

Brown Cancer Center first in state to provide new melanoma drug

A newly FDA-approved treatment for patients with advanced or inoperable melanoma who are no longer responding to other drugs is now available to patients at the University of Louisville’s James Graham Brown Cancer Center, a part of KentuckyOne Health. As a site for Keytruda’s research clinical trial, the cancer center is the first in Kentucky to offer the drug now that it is approved.

Research!Louisville focuses on research at Louisville Medical Center, Sept. 16-19

Research in cancer biology, spinal cord injury, birth defects, circulatory support devices and more will highlight Research!Louisville 2014, Sept. 16-19 at various locations in the Louisville Medical Center.